Research graph
References from Rethinking Value in Cancer Care in the US. Local targets link to admitted publications; unresolved targets remain external evidence.
Medical care costs associated with cancer survivorship in the United States.
10.1158/1055-9965.epi-19-1534 · 2020 · External reference
Trends in launch prices and price increases for self-administered anticancer drugs in Medicare.
10.1001/jama.2025.6366 · 2025 · External reference
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): extended long-term outcomes.
10.1016/j.ijrobp.2022.05.004 · 2022 · External reference
Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer.
10.1056/nejmoa2202809 · 2022 · External reference
Implications of Medicare negotiation and most-favored-nation pricing for cancer medicine costs.
10.1001/jamahealthforum.2026.0509 · 2026 · External reference
An international modified Delphi study to prioritise levels of evidence and outcomes to appraise radiotherapy innovation in the ESTRO Value-Based Radiation Oncology framework.
10.1016/s1470-2045(25)00732-6 · 2026 · External reference
Unresolved reference
External reference
